Moreover, we unveiled that glioma samples from patients at high grades (WHO3-WHO4 grades) expressed higher LEF1-AS1 than those from patients at less malignant grades (WHO1-WHO2 grades) (Fig. S1e). The gene discussed is LEF1; the disease is glioma.